Osmind

21/07/2025

Thinking about accepting insurance at your psychiatry practice? It can seem overwhelming, but with the right roadmap, it's absolutely manageable.

Most practices expect a 2-month timeline. Smart practices plan for 4-6 months.

You're working with payer approval processes and committee meetings on schedules you can't control. When you understand the dependency chain—contract approval, then credentialing, then EDI enrollment—you can plan accordingly.

If you're offering TMS or Spravato, there are additional steps, but they're predictable once you know what to expect.

Just like in medicine, an ounce of prevention is worth a pound of cure.
The key is having a clear timeline, proper documentation, and the right billing partner who understands psychiatry's unique requirements.

Our complete guide walks you through each step so you can expand your practice with confidence:

Start taking insurance with confidence. Learn the essential timeline, documentation, and partner selection strategies that set successful psychiatry practices up for insurance success.

18/07/2025

Happening Wednesday, July 23rd, 9AM - 9:30 AM PDT: Join us for an informal coffee chat hosted by Osmind CMO, William Sauvé, MD and Don Vaughn, Ph.D., CEO of Ampa, for a live Q&A to get all your questions about Ampa answered!

No slides, no lectures—just real talk with fellow clinicians and a cup a of coffee!

☕ What we’ll chat about:
•Tips for running & growing your practice
•What’s new in interventional psychiatry (Spravato, TMS, psychedelics, etc.)
•Anything else you want to bring up!

We’ll have a topic to kick things off, but it’s an open mic—jump in with your own questions or ideas.

Bring questions or topics or just listen in!

Links to RSVP in comments 👇

16/07/2025

The FDA has invited our Chief Medical Officer, William Sauvé, MD, to present at this Friday's Psychopharmacologic Drugs Advisory Committee. The Committee will review the supplemental new drug application submitted by Otsuka for brexpiprazole tablets, in combination with sertraline, as a potential treatment for adults with PTSD.

The FDA convenes advisory committees for critical public health matters—PTSD affects 5-6% of Americans annually, with higher rates among veterans.
Dr. Sauve's expertise spans military psychiatry, inpatient PTSD programs, and clinical innovation at Osmind.

He will address treatment gaps and advocate for higher standards of care, bringing decades of frontline experience to regulatory discussions that shape treatment advancement.

The meeting streams live and archives for later viewing—essential viewing for anyone developing PTSD treatments or seeking better patient outcomes.

Watch here: https://www.fda.gov/advisory-committees/advisory-committee-calendar/july-18-2025-meeting-psychopharmacologic-drugs-advisory-committee-meeting-announcement-07182025

11/07/2025

Happening Thursday, Jul 17 at 11:00 AM - 11:30 AM PDT: Join two TMS pioneers, Martha B. Koo, M.D., LFAPA, FASAM, FCTMSS and William Sauvé, MD, for our live Psychiatry Collective event.

Discuss all things psychiatry with fellow forward-thinking clinicians:

🔹 Practical Guidance on Running & Growing Your Practice: Get expert strategies on financial sustainability, workflow optimization, staff management, and insurance navigation.

🔹 Insights on Interventional Psychiatry: Stay up to date on Spravato, TMS, psychedelics, neuromodulation, and the latest advancements in psychiatric care.

🔹 A Collaborative, Informal Discussion: No slides or lectures—just candid conversations and peer-driven learning in a supportive environment.

Bring questions or topics or just listen in!
Links to RSVP in comments 👇

10/07/2025

🚨 Every Spravato practice needs this.

The FDA requires specific consent procedures for Spravato treatments. Get it wrong = regulatory violations, liability risks, and claim denials.

We've created a comprehensive consent form that covers:

✅ Complete FDA/REMS compliance with all required safety information

✅ Legal protection through professionally drafted language covering risks, alternatives, and patient responsibilities

✅ Insurance optimization with proper documentation to support prior authorizations and reduce claim denials

✅ Patient-friendly format that improves understanding and treatment compliance

Skip the hours of research and drafting. Download our proven template 📋

Get a free, FDA-compliant Spravato consent form that covers all REMS requirements and protects your practice from regulatory violations and liability risks. Download our template to streamline patient consent and reduce administrative burden.

08/07/2025

Here's what you're missing this month in the Osmind Psychiatry Collective:

•Psychedelics for treating substance abuse: Brittany Albright MD, MPH shared research on psychedelics showing 66% of participants reduced alcohol consumption and 49% decreased to***co use after psychedelic experiences. The study also found 48-72% reported better impulse control. "This study opens the door to future research examining psychedelics and their effects on wellness, not simply psychopathology," she noted.

•Metabolic Psychiatry: Bret Scher, MD, sparked discussion by sharing Christopher Palmer, MD's perspective: "Mental health disorders are metabolic disorders of the brain." Members dove into the strong connections between metabolic and mental health, with clinicians sharing success stories from implementing ketogenic therapy as adjuvant treatment.

•The age of AI: William Sauvé, MD sparked a discussion on AI vs. physician diagnostics. Some members expressed concerns about AI replacing human empathy in therapy, while others questioned whether we're training doctors to win at computer games rather than practice actual medicine. The conversation touched on everything from neuropsychological testing to whether patients actually prefer AI therapists.

80 new members joined just in the last month, sharing real-world insights you don't find in journals alone.

Join the discussion, including weekly live virtual events.

(links in comments below 👇)

01/07/2025

"When patients tell me they feel 100% for the first time in years—restored, clear-headed and free of medication side effects" — Dr. Martha B. Koo, M.D., LFAPA, FASAM, FCTMSS joins Osmind as Medical Advisor, bringing expertise as a founding member of the Clinical TMS Society, and founder of Your Behavioral Health's 30+ locations across Southern California.

Her three-part vision for transforming mental healthcare:

•Move beyond "good enough" psychiatry: "Other medical specialties would never accept this standard. In psychiatry, we routinely start with medications that only have a 30% remission rate when treatments like TMS can achieve so much more."

•Prioritize prevention and precision: "Instead of waiting for symptoms, a diagnosis and then treatment, we need to prioritize prevention. I envision a world where we have identified the biomarkers predicting future illness, and we possess the technology to know the most effective treatment for every individual."

•Build infrastructure for breakthrough treatments: "We need systems that make it easier for clinicians to deliver evidence-based care and we need researchers to understand what's actually working in real-world clinical settings."

Read Dr. Koo's full perspective: https://www.osmind.org/blog/martha-koo-medical-advisor

24/06/2025

Your practice may be hemorrhaging money, and you probably don't even realize it.Prior authorization hits psychiatry harder than almost any other specialty—57% of our services compared to 30% elsewhere.

If you offer Spravato or TMS, your headache multiplies.Here's the reality you'll find in our latest blog:

•Why 78-82% of psychiatric patients abandon treatment due to PA barriers

•The hidden costs of Spravato/TMS authorization delays ($49K+ annually per patient)

•Why hiring a PA specialist typically backfires and costs even more

But change might actually be coming.

Yesterday, HHS Secretary Kennedy and CMS Administrator Dr. Oz got major insurers—Aetna, BCBS, Cigna, Humana, UnitedHealthcare, and others—to pledge fixes to the broken prior auth system by 2026-2027.

Their promises sound good on paper. We've heard promises before.

Smart practices aren't waiting around to find out.

The ones getting prior auths right already have solutions and systems in place that positively impact their bottom line and patient care.

We broke down exactly what they're doing differently:

Psychiatric practices face prior authorization requirements at nearly double the rate of other medical specialties, creating hidden costs that most practice owners don't see until it's too late. From delays for standard medications to waits for Spravato and TMS treatments, discover the true financia...

23/06/2025

Our CEO and co-founder, Lucia Huang, spoke on a panel titled "Technology Across the Psychedelic Continuum" at Psychedelic Science 2025, the largest psychedelic conference of its kind.

Joined by industry leaders Danielle Schlosser, PhD and Julie Friedman Simon, moderated by Matias Serebrinsky, the panel explored how technology is transforming every phase of the psychedelic ecosystem:

° How specialized electronic health records enhance data collection and patient outcomes

° The role of AI-driven communication analytics in psychedelic medicine

° What a tech-enabled continuum of care looks like—and what gaps still need filling.

With billions of dollars flowing into psychedelic research and development, these conversations are shaping the future of technology in advancing psychedelic medicine and improving mental healthcare for patients in need. We're proud to contribute to the dialogue.

Osmind combines real-world data, clinical technology, and practice services to advance the responsible development and delivery of breakthrough mental health treatments to those who need it most.

18/06/2025

We're back from the Clinical TMS Society 13th Annual Meeting, and are feeling energized by the new research and the shared commitment to advance TMS.

Dr. William Sauvé, MD, Osmind's Chief Medical Officer, presented "Clinical Outcomes in Patients Treated with Neurostar and Brainsway TMS Therapy Devices," showcasing real-world data from over thousands of TMS treatments.

Thank you to everyone who stopped by and connected with our team. We're proud to sponsor both Clinical TMS Society and Foundation for the Advancement of Clinical TMS (FACTMS) as we work together to expand TMS accessibility and bring life-saving treatments to those who need it most.

Let’s continue the conversation in the Psychiatry Collective (osmind.org/join-community).

16/06/2025

Happening Thursday: Join our live Psychiatry Collective event at 11 am PT / 2 pm ET

Connect with clinical experts and fellow forward-thinking clinicians for an informal live discussion designed to help you navigate the evolving landscape of psychiatric care and practice management.

Discuss all things psychiatry:

🔹 Practical Guidance on Running & Growing Your Practice – Get expert strategies on financial sustainability, workflow optimization, staff management, and insurance navigation.

🔹 Insights on Interventional Psychiatry – Stay up to date on Spravato, TMS, psychedelics, neuromodulation, and the latest advancements in psychiatric care.

🔹 A Collaborative, Informal Discussion – No slides or lectures—just candid conversations and peer-driven learning in a supportive environment.

Bring questions or topics or just listen in!

RSVP here: https://community.osmind.org/c/events/live-event-discussing-all-brain-matters-765816

Not a Psychiatry Collective member yet? Sign up here: http://osmind.org/join-community?utm_source=post&utm_medium=social&utm_campaign=community-live-event

11/06/2025

🎯 60 million patients. 70,000 clinicians (an intentionally optimistic number). Even at maximum capacity, the math doesn't work

Here's the uncomfortable truth: If every psychiatrist and APP in America saw 4 patients per hour, every hour, every day, we'd still fall short of meeting mental health demand.

But give me a big enough lever, and I can move mental healthcare mountains.

During William Sauvé, MD deployment in Iraq's Al Anbar province, he learned about "force multipliers"— strategic tools that exponentially increase impact without adding resources.

One Navy Corpsman with psychiatric training could do 95% of what he could do, effectively doubling the unit's mental health capacity.

The same principle applies to psychiatric practice:

✅ Smart triage systems that match patients to the right resources faster

✅ Strategic use of TMS and esketamine to free up med management slots

✅ Collaborative networks where practices share expertise, not compete for patients

✅ Tech that scales care beyond the 15-minute med check

The shortage isn't going away. But psychiatrists who understand force multipliers can serve more patients, achieve better outcomes, and avoid burnout.

Read the full breakdown: https://www.osmind.org/blog/force-multipliers

What force multipliers are you already using in your practice?

Sixty million Americans need mental health treatment. Seventy thousand psychiatrists and APPs exist to serve them. Even if every clinician worked at maximum capacity—four patients per hour, every hour, every day—we'd still fall short. The math doesn't work. This article explores “force multipl...